Afatinib is a targeted therapy drug that is also known as Giotrif®. It is used to treat non-small cell lung cancer (NSCLC) that has started to spread outside the lung or to other parts of the body. It may also be used to treat other cancers as part of a clinical trial.
It is best to read this information with our general information about lung cancer or the type of cancer you have.
Your doctor will talk to you about this treatment and its possible side effects before you agree (consent) to have treatment.
During treatment, you will see a cancer doctor or nurse. This is who we mean when we mention a doctor or nurse in this information.